XML 28 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Subsequent Events
12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events

9. Subsequent Events

The Company and Purchaser entered into the Asset Purchase Option Agreement dated September 15, 2021 (see Note 1 for further details), pursuant to which the Company granted to Purchaser an exclusive option during a fixed period of time to negotiate a definitive asset purchase agreement to acquire one of the Company's preclinical programs. On January 18, 2022, the Purchaser provided written notice to the Company of its intent to exercise such Option. On March 1, 2022 the Company and the Purchaser entered into the Asset Purchase Agreement and the Option fee of $0.5 million was paid to the Company.